Real-world effectiveness of second-line Afatinib versus chemotherapy for the treatment of advanced lung squamous cell carcinoma in immunotherapy-naïve patients

BACKGROUND: Limited treatment options exist for relapsed advanced lung squamous cell carcinoma (SCC), leading to poor outcomes compared with adenocarcinoma. This study aimed to investigate the efficacy of second-line afatinib versus chemotherapy in patients with advanced lung SCC who progressed afte...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, You-Yi, Chang, Shih-Chieh, Chang, Cheng-Yu, Chang, Chun-Fu, Lai, Yi-Chun, Wei, Yu-Feng, Chen, Chung-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594240/
https://www.ncbi.nlm.nih.gov/pubmed/34781919
http://dx.doi.org/10.1186/s12885-021-08920-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594240/
https://www.ncbi.nlm.nih.gov/pubmed/34781919
http://dx.doi.org/10.1186/s12885-021-08920-3

Ejemplares similares